Attachments
- Original document
- Permalink
Disclaimer
Roche Holding AG published this content on 20 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 July 2021 06:41:12 UTC.
Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
219,8 CHF | +0,48 % | -0,90 % | -9,98 % |
13:58 | Roches Lungenkrebsmedikament Alecensa wird in der EU zugelassen | MT |
13:53 | Roche kommt EU-Zulassung für Krebsmittel Alecensa einen Schritt näher | AW |
Attachments
Disclaimer
Roche Holding AG published this content on 20 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 July 2021 06:41:12 UTC.
% 1. Jan. | Kap. | |
---|---|---|
-9,98 % | 193 Mrd. | |
+25,70 % | 556 Mrd. | |
-6,33 % | 354 Mrd. | |
+19,90 % | 331 Mrd. | |
+7,95 % | 296 Mrd. | |
+12,89 % | 233 Mrd. | |
+5,27 % | 201 Mrd. | |
-12,26 % | 143 Mrd. | |
-6,47 % | 144 Mrd. | |
+0,70 % | 123 Mrd. |